[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Heparin Market Size, Share & Trends Analysis Report By Type (Low Molecular Weight Heparin, Unfractionated Heparin), By Route Of Administration, By Application, By End-use, By Source, By Region, And Segment Forecasts, 2022 - 2030

July 2022 | 100 pages | ID: H3667D184AD6EN
Grand View Research, Inc.

US$ 5,950.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
This report can be delivered to the clients within 5 Business Days

Heparin Market Growth & Trends

The global heparin market size is expected to reach USD 9.0 billion by 2030, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 2.4% from 2022 to 2030. The increasing geriatric population and heightened demand for transfusions are key factors propelling the market growth. Moreover, the outbreak of the COVID-19 has further propelled market growth. For instance, as per The Lancet Journal in 2022, the demand for heparin exacerbated attributable to its use in COVID-19 patients for thromboprophylaxis.

Increasing demand for blood components, transfusion, and plasma derivatives in the treatment of infectious diseases are expected to drive the market. For instance, according to American Red Cross in 2022, around 16 million blood components are transfused each year in the U.S. Furthermore, the surge in the number of surgeries that were delayed due to the COVID-19 pandemic has further escalated the demand for heparin for blood-clot prevention.

The growing geriatric population is estimated to fuel the market growth. According to United Nations, it was estimated that, in 2020, there were around 727 million people with ages above 60 years worldwide. In addition, the percentage share of the aged population above 65 years is estimated to increase from 9.3% to 2020 to 16% in 2050. The geriatric population has a higher rate of complex surgeries and thus is anticipated to propel the demand for heparin as an anticoagulant, as this population has a significantly higher rate of developing blood clots and related conditions such as deep vein thrombosis.

Growing number of surgeries is a key factor accelerating the demand for whole blood and transfusions. For instance, the annual number of major surgeries performed globally has reached 310 million, 40 to 50 million surgeries performed in the U.S., and around 20 million were performed in Europe in 2020. These surgeries are projected to escalate the demand for heparin.

The competitive rivalry in the marketplace is expected to be moderate due to changing dynamics towards oral anticoagulants. The involvement of players in discovering novel routes of administration for anticoagulants such as heparin is expected to change the market scenario over the forecast period. Rising number of players offering generics also increases competitive rivalry.

Heparin Market Report Highlights
  • The Low Molecular Weight Heparin (LMWH) segment held the largest revenue share in 2021 owing to its high prescription rate and demand
  • The subcutaneous route of administration segment held the largest revenue share in 2021 owing to its cost-effective nature and easier procedure for administration
  • The coronary artery disease segment dominated the market in 2021 owing to the rising incidence of coronary artery disease and increased use of heparin injection in hospitalized patients
  • The outpatient segment is expected to hold the largest revenue share in 2021 owing to the initiatives undertaken by hospitals for outpatient services and increased preference of patients for outpatient treatment
  • Porcine derived heparin is expected to dominate the market due to its use in the production of low molecular weight heparin
  • Asia Pacific is expected to exhibit the fastest growth over the forecast period due to the growing establishment of healthcare, and a large population base
CHAPTER 1 METHODOLOGY AND SCOPE

1.1 Market Segmentation and Scope
  1.1.1 Segment scope
  1.1.2 Regional scope
  1.1.3 Estimates and forecast timeline
1.2 Research Methodology
1.3 Information Procurement
  1.3.1 Purchased database:
  1.3.2 GVR’s internal database
  1.3.3 Secondary sources
  1.3.4 Primary research
  1.3.5 Details of primary research
1.4 Information or Data Analysis
  1.4.1 Data analysis models
1.5 Market Formulation & Validation
1.6 Model Details
  1.6.1 Commodity Flow Analysis
    1.6.1.1 Approach: Commodity Flow Approach
1.7 Research Assumptions
1.8 List of Secondary Sources
1.9 List of Abbreviations
1.10 Objectives
  1.10.1 Objective
  1.10.2 Objective
  1.10.3 Objective
  1.10.4 Objective

CHAPTER 2 EXECUTIVE SUMMARY

2.1 Market Outlook
2.2 Competitive Insights

CHAPTER 3 HEPARIN MARKET VARIABLES, TRENDS, & SCOPE

3.1 Market Lineage Outlook
  3.1.1 Parent market
3.2 Market Dynamics
  3.2.1 Market drivers analysis
    3.2.1.1 Increasing prevalence of chronic diseases
    3.2.1.2 Growing demand for whole blood and blood components transfusion
    3.2.1.3 Increasing geriatric population
    3.2.1.4 High usage of plasma in pharmaceutical industry
  3.2.2 Market restraint analysis
    3.2.2.1 Risk of blood transmitted diseases and increasing number of blood substitutes
    3.2.2.2 Emerging oral anticoagulants
3.3 Penetration & Growth Prospect Mapping
3.4 Heparin: Market Analysis Tools
  3.4.1 Industry analysis - Porter’s
  3.4.2 PESTLE analysis
3.5 Regulatory Framework
3.6 Pricing Analysis

CHAPTER 4 HEPARIN MARKET SEGMENT ANALYSIS, BY TYPE, 2018 - 2030 (USD MILLION)

4.1 Definition and Scope
4.2 Type Market Share Analysis, 2021 & 2030
4.3 Segment Dashboard
4.4 Global Heparin Market, by Type, 2018 to 2030
4.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
  4.5.1 Low Molecular Weight Heparin (LMWH)
    4.5.1.1 Low molecular weight heparin market, 2018 - 2030 (USD Million)
  4.5.2 Ultra-Low Molecular Weight Heparin (ULMWH)
    4.5.2.1 Ultra-Low molecular weight heparin market, 2018 - 2030 (USD Million)
  4.5.3 Unfractionated Heparin
    4.5.3.1 Unfractionated heparin market, 2018 - 2030 (USD Million)

CHAPTER 5 HEPARIN MARKET SEGMENT ANALYSIS, BY ROUTE OF ADMINISTRATION, 2018 - 2030 (USD MILLION)

5.1 Definition and Scope
5.2 Route of Administration Market Share Analysis, 2021 & 2030
5.3 Segment Dashboard
5.4 Global Heparin Market, by Route of Administration, 2018 to 2030
5.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
  5.5.1 Intravenous
    5.5.1.1 Intravenous market, 2018 - 2030 (USD Million)
  5.5.2 Subcutaneous
    5.5.2.1 Subcutaneous market, 2018 - 2030 (USD Million)

CHAPTER 6 HEPARIN MARKET SEGMENT ANALYSIS, BY APPLICATION, 2018 - 2030 (USD MILLION)

6.1 Definition and Scope
6.2 Application Market Share Analysis, 2021 & 2030
6.3 Segment Dashboard
6.4 Global Heparin Market, by Application, 2018 to 2030
6.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
  6.5.1 Venous Thromboembolism
    6.5.1.1 Venous thromboembolism market, 2018 - 2030 (USD Million)
  6.5.2 Coronary Artery Disease
    6.5.2.1 Coronary artery disease market, 2018 - 2030 (USD Million)
  6.5.3 Renal Impairment
    6.5.3.1 Renal impairment market, 2018 - 2030 (USD Million)
  6.5.4 Atrial Fibrillation
    6.5.4.1 Atrial fibrillation market, 2018 - 2030 (USD Million)
  6.5.5 Others
    6.5.5.1 Others market, 2018 - 2030 (USD Million)

CHAPTER 7 HEPARIN MARKET SEGMENT ANALYSIS, BY END-USE, 2018 - 2030 (USD MILLION)

7.1 Definition and Scope
7.2 End-use Market Share Analysis, 2021 & 2030
7.3 Segment Dashboard
7.4 Global Heparin Market, by End-use, 2018 to 2030
7.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
  7.5.1 Outpatient
    7.5.1.1 Outpatient market, 2018 - 2030 (USD Million)
  7.5.2 Inpatient
    7.5.2.1 Inpatient market, 2018 - 2030 (USD Million)

CHAPTER 8 HEPARIN MARKET SEGMENT ANALYSIS, BY SOURCE, 2018 - 2030 (USD MILLION)

8.1 Definition and Scope
8.2 Source Market Share Analysis, 2021 & 2030
8.3 Segment Dashboard
8.4 Global Heparin Market, by Source, 2018 to 2030
8.5 Market Size & Forecasts and Trend Analyses, 2018 to 2030
  8.5.1 Porcine
    8.5.1.1 Porcine market, 2018 - 2030 (USD Million)
  8.5.2 Bovine
    8.5.2.1 Bovine market, 2018 - 2030 (USD Million)
  8.5.3 Others
    8.5.3.1 Others market, 2018 - 2030 (USD Million)

CHAPTER 9 HEPARIN MARKET SEGMENT ANALYSIS, BY REGION, 2018 - 2030 (USD MILLION)

9.1 Definition & Scope
9.2 Regional Market Share Analysis, 2021 & 2030
9.3 Regional Market Dashboard
9.4 Regional Market Snapshot
9.5 SWOT Analysis
  9.5.1 North America
  9.5.2 Europe
  9.5.3 Asia Pacific
  9.5.4 Latin America
  9.5.5 Middle East and Africa
9.6 Market Size, & Forecasts, Revenue and Trend Analysis, 2021 to 2030
  9.6.1 North America
    9.6.1.1 North America market estimates and forecast, 2018 - 2030 (USD Million)
    9.6.1.2 U.S.
      9.6.1.2.1 U.S. heparin market, 2018 - 2030 (USD Million)
    9.6.1.3 Canada
      9.6.1.3.1 Canada heparin market, 2018 - 2030 (USD Million)
  9.6.2 Europe
    9.6.2.1 Europe heparin market, 2018 - 2030 (USD Million)
    9.6.2.2 U.K.
      9.6.2.2.1 U.K. heparin market, 2018 - 2030 (USD Million)
    9.6.2.3 Germany
      9.6.2.3.1 Germany heparin market, 2018 - 2030 (USD Million)
    9.6.2.4 Spain
      9.6.2.4.1 Spain heparin market, 2018 - 2030 (USD Million)
    9.6.2.5 France
      9.6.2.5.1 France heparin market, 2018 - 2030 (USD Million)
    9.6.2.6 Italy
      9.6.2.6.1 Italy heparin market, 2018 - 2030 (USD Million)
    9.6.2.7 Russia
      9.6.2.7.1 Russia heparin market, 2018 - 2030 (USD Million)
  9.6.3 Asia Pacific
    9.6.3.1 Asia Pacific heparin market, 2018 - 2030 (USD Million)
    9.6.3.2 Japan
      9.6.3.2.1 Japan heparin market, 2018 - 2030 (USD Million)
    9.6.3.3 China
      9.6.3.3.1 China heparin market, 2018 - 2030 (USD Million)
    9.6.3.4 India
      9.6.3.4.1 India heparin market, 2018 - 2030 (USD Million)
    9.6.3.5 South Korea
      9.6.3.5.1 South Korea heparin market, 2018 - 2030 (USD Million)
    9.6.3.6 Australia
      9.6.3.6.1 Australia heparin market, 2018 - 2030 (USD Million)
    9.6.3.7 Singapore
      9.6.3.7.1 Singapore heparin market, 2018 - 2030 (USD Million)
  9.6.4 Latin America
    9.6.4.1 Latin America heparin market, 2018 - 2030 (USD Million)
    9.6.4.2 Brazil
      9.6.4.2.1 Brazil heparin market, 2018 - 2030 (USD Million)
    9.6.4.3 Mexico
      9.6.4.3.1 Mexico heparin market, 2018 - 2030 (USD Million)
    9.6.4.4 Argentina
      9.6.4.4.1 Argentina heparin market, 2018 - 2030 (USD Million)
  9.6.5 MEA
    9.6.5.1 MEA heparin market, 2018 - 2030 (USD Million)
    9.6.5.2 South Africa
      9.6.5.2.1 South Africa heparin market, 2018 - 2030 (USD Million)
    9.6.5.3 Saudi Arabia
      9.6.5.3.1 Saudi Arabia heparin market, 2018 - 2030 (USD Million)
    9.6.5.4 UAE
      9.6.5.4.1 UAE heparin market, 2018 - 2030 (USD Million)

CHAPTER 10 HEPARIN MARKET - COMPETITIVE ANALYSIS

10.1 Recent Developments & Impact Analysis, by Key Market Participants
  10.1.1 Ansoff matrix
  10.1.2 Heat map analysis
  10.1.3 Major Deals and Strategic Alliances Analysis
    10.1.3.1 Joint Ventures
    10.1.3.2 Licensing Agreements
    10.1.3.3 Product Launches
    10.1.3.4 Conferences and Campaigns
10.2 Company Categorization
  10.2.1 Innovators
  10.2.2 Market Leaders
10.3 Vendor Landscape
  10.3.1 List of key distributors and channel partners
  10.3.2 Key customers
10.4 Public Companies
  10.4.1 Competitive Dashboard Analysis
  10.4.2 Market Differentiators
10.5 Private Companies
  10.5.1 List of key emerging companies
10.6 Company Profiles
  10.6.1 GlaxoSmithKline plc (GSK)
    10.6.1.1 Company overview
    10.6.1.2 Financial performance
    10.6.1.3 Product benchmarking
    10.6.1.4 Strategic Initiatives
  10.6.2 Pfizer Inc.
    10.6.2.1 Company overview
    10.6.2.2 Financial performance
    10.6.2.3 Product benchmarking
    10.6.2.4 Strategic Initiatives
  10.6.3 LEO Pharma A/S
    10.6.3.1 Company overview
    10.6.3.2 Financial performance
    10.6.3.3 Product benchmarking
    10.6.3.4 Strategic Initiatives
  10.6.4 Sanofi
    10.6.4.1 Company overview
    10.6.4.2 Financial performance
    10.6.4.3 Product benchmarking
    10.6.4.4 Strategic Initiatives
  10.6.5 Dr. Reddy’s Laboratories Ltd.
    10.6.5.1 Company overview
    10.6.5.2 Financial performance
    10.6.5.3 Product benchmarking
    10.6.5.4 Strategic Initiatives
  10.6.6 Aspen Holdings
    10.6.6.1 Company overview
    10.6.6.2 Financial performance
    10.6.6.3 Product benchmarking
    10.6.6.4 Strategic Initiatives
  10.6.7 B. Braun Medical Inc.
    10.6.7.1 Company overview
    10.6.7.2 Financial performance
    10.6.7.3 Product benchmarking
    10.6.7.4 Strategic initiatives
  10.6.8 Fresenius SE & Co. KGaA
    10.6.8.1 Company overview
    10.6.8.2 Financial performance
    10.6.8.3 Product benchmarking
    10.6.8.4 Strategic initiatives
  10.6.9 Sandoz (Novartis AG)
    10.6.9.1 Company overview
    10.6.9.2 Financial performance
    10.6.9.3 Product benchmarking
    10.6.9.4 Strategic initiatives
LIST OF TABLES

Table 1 List of secondary sources
Table 2 List of abbreviations
Table 3 Leading market players anticipated to witness highest growth
Table 4 Global Heparin Market, By Region, 2018 - 2030 (USD Million)
Table 5 Global Heparin Market, By Type, 2018 - 2030 (USD Million)
Table 6 Global Heparin Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 7 Global Heparin Market, By Application, 2018 - 2030 (USD Million)
Table 8 Global Heparin Market, By End-use, 2018 - 2030 (USD Million)
Table 9 Global Heparin Market, By Source, 2018 - 2030 (USD Million)
Table 10 North America Heparin Market, By Country, 2018 - 2030 (USD Million)
Table 11 North America Heparin Market, By Type, 2018 - 2030 (USD Million)
Table 12 North America Heparin Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 13 North America Heparin Market, By Application, 2018 - 2030 (USD Million)
Table 14 North America Heparin Market, By End-use, 2018 - 2030 (USD Million)
Table 15 North America Heparin Market, By Source, 2018 - 2030 (USD Million)
Table 16 U.S. Heparin Market, By Type, 2018 - 2030 (USD Million)
Table 17 U.S. Heparin Market, By Application, 2018 - 2030 (USD Million)
Table 18 U.S. Heparin Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 19 U.S. Heparin Market, By End-use, 2018 - 2030 (USD Million)
Table 20 U.S. Heparin Market, By Source, 2018 - 2030 (USD Million)
Table 21 Canada Heparin Market, By Type, 2018 - 2030 (USD Million)
Table 22 Canada Heparin Market, By Application, 2018 - 2030 (USD Million)
Table 23 Canada Heparin Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 24 Canada Heparin Market, By End-use, 2018 - 2030 (USD Million)
Table 25 Canada Heparin Market, By Source, 2018 - 2030 (USD Million)
Table 26 Europe Heparin Market, By Country, 2018 - 2030 (USD Million)
Table 27 Europe Heparin Market, By Type, 2018 - 2030 (USD Million)
Table 28 Europe Heparin Market, By Application, 2018 - 2030 (USD Million)
Table 29 Europe Heparin Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 30 Europe Heparin Market, By End-use, 2018 - 2030 (USD Million)
Table 31 Europe Heparin Market, By Source, 2018 - 2030 (USD Million)
Table 32 Germany Heparin Market, By Type, 2018 - 2030 (USD Million)
Table 33 Germany Heparin Market, By Application, 2018 - 2030 (USD Million)
Table 34 Germany Heparin Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 35 Germany Heparin Market, By End-use, 2018 - 2030 (USD Million)
Table 36 Germany Heparin Market, By Source, 2018 - 2030 (USD Million)
Table 37 U.K. Heparin Market, By Type, 2018 - 2030 (USD Million)
Table 38 U.K. Heparin Market, By Application, 2018 - 2030 (USD Million)
Table 39 U.K. Heparin Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 40 U.K. Heparin Market, By End-use, 2018 - 2030 (USD Million)
Table 41 U.K. Heparin Market, By Source, 2018 - 2030 (USD Million)
Table 42 France Heparin Market, By Type, 2018 - 2030 (USD Million)
Table 43 France Heparin Market, By Application, 2018 - 2030 (USD Million)
Table 44 France Heparin Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 45 France Heparin Market, By End-use, 2018 - 2030 (USD Million)
Table 46 France Heparin Market, By Source, 2018 - 2030 (USD Million)
Table 47 Italy Heparin Market, By Type, 2018 - 2030 (USD Million)
Table 48 Italy Heparin Market, By Application, 2018 - 2030 (USD Million)
Table 49 Italy Heparin Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 50 Italy Heparin Market, By End-use, 2018 - 2030 (USD Million)
Table 51 Italy Heparin Market, By Source, 2018 - 2030 (USD Million)
Table 52 Spain Heparin Market, By Type, 2018 - 2030 (USD Million)
Table 53 Spain Heparin Market, By Application, 2018 - 2030 (USD Million)
Table 54 Spain Heparin Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 55 Spain Heparin Market, By End-use, 2018 - 2030 (USD Million)
Table 56 Spain Heparin Market, By Source, 2018 - 2030 (USD Million)
Table 57 Russia Heparin Market, By Type, 2018 - 2030 (USD Million)
Table 58 Russia Heparin Market, By Application, 2018 - 2030 (USD Million)
Table 59 Russia Heparin Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 60 Russia Heparin Market, By End-use, 2018 - 2030 (USD Million)
Table 61 Russia Heparin Market, By Source, 2018 - 2030 (USD Million)
Table 62 Asia Pacific Heparin Market, By Country, 2018 - 2030 (USD Million)
Table 63 Asia Pacific Heparin Market, By Type, 2018 - 2030 (USD Million)
Table 64 Asia Pacific Heparin Market, By Application, 2018 - 2030 (USD Million)
Table 65 Asia Pacific Heparin Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 66 Asia Pacific Heparin Market, By End-use, 2018 - 2030 (USD Million)
Table 67 Asia Pacific Heparin Market, By Source, 2018 - 2030 (USD Million)
Table 68 Japan Heparin Market, By Type, 2018 - 2030 (USD Million)
Table 69 Japan Heparin Market, By Application 2018 - 2030 (USD Million)
Table 70 Japan Heparin Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 71 Japan Heparin Market, By End-use, 2018 - 2030 (USD Million)
Table 72 Japan Heparin Market, By Source, 2018 - 2030 (USD Million)
Table 73 China Heparin Market, By Type, 2018 - 2030 (USD Million)
Table 74 China Heparin Market, By Application, 2018 - 2030 (USD Million)
Table 75 China Heparin Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 76 China Heparin Market, By End-use, 2018 - 2030 (USD Million)
Table 77 China Heparin Market, By Source, 2018 - 2030 (USD Million)
Table 78 India Heparin Market, By Type, 2018 - 2030 (USD Million)
Table 79 India Heparin Market, By Application, 2018 - 2030 (USD Million)
Table 80 India Heparin Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 81 India Heparin Market, By End-use, 2018 - 2030 (USD Million)
Table 82 India Heparin Market, By Source, 2018 - 2030 (USD Million)
Table 83 Australia Heparin Market, By Type, 2018 - 2030 (USD Million)
Table 84 Australia Heparin Market, By Application, 2018 - 2030 (USD Million)
Table 85 Australia Heparin Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 86 Australia Heparin Market, By End-use, 2018 - 2030 (USD Million)
Table 87 Australia Heparin Market, By Source, 2018 - 2030 (USD Million)
Table 88 Singapore Heparin Market, By Type, 2018 - 2030 (USD Million)
Table 89 Singapore Heparin Market, By Application, 2018 - 2030 (USD Million)
Table 90 Singapore Heparin Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 91 Singapore Heparin Market, By End-use, 2018 - 2030 (USD Million)
Table 92 Singapore Heparin Market, By Source, 2018 - 2030 (USD Million)
Table 93 South Korea Heparin Market, By Type, 2018 - 2030 (USD Million)
Table 94 South Korea Heparin Market, By Application, 2018 - 2030 (USD Million)
Table 95 South Korea Heparin Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 96 South Korea Heparin Market, By End-use, 2018 - 2030 (USD Million)
Table 97 South Korea Heparin Market, By Source, 2018 - 2030 (USD Million)
Table 98 Latin America Heparin Market, By Country, 2018 - 2030 (USD Million)
Table 99 Latin America Heparin Market, By Type, 2018 - 2030 (USD Million)
Table 100 Latin America Heparin Market, By Application, 2018 - 2030 (USD Million)
Table 101 Latin America Heparin Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 102 Latin America Heparin Market, By End-use, 2018 - 2030 (USD Million)
Table 103 Latin America Heparin Market, By Source, 2018 - 2030 (USD Million)
Table 104 Brazil Heparin Market, By Type, 2018 - 2030 (USD Million)
Table 105 Brazil Heparin Market, By Application 2018 - 2030 (USD Million)
Table 106 Brazil Heparin Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 107 Brazil Heparin Market, By End-use, 2018 - 2030 (USD Million)
Table 108 Brazil Heparin Market, By Source, 2018 - 2030 (USD Million)
Table 109 Mexico Heparin Market, By Type, 2018 - 2030 (USD Million)
Table 110 Mexico Heparin Market, By Application, 2018 - 2030 (USD Million)
Table 111 Mexico Heparin Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 112 Mexico Heparin Market, By End-use, 2018 - 2030 (USD Million)
Table 113 Mexico Heparin Market, By Source, 2018 - 2030 (USD Million)
Table 114 Argentina Heparin Market, By Type, 2018 - 2030 (USD Million)
Table 115 Argentina Heparin Market, By Application, 2018 - 2030 (USD Million)
Table 116 Argentina Heparin Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 117 Argentina Heparin Market, By End-use, 2018 - 2030 (USD Million)
Table 118 Argentina Heparin Market, By Source, 2018 - 2030 (USD Million)
Table 119 Middle East & Africa Heparin Market, By Country, 2018 - 2030 (USD Million)
Table 120 Middle East & Africa Heparin Market, By Type, 2018 - 2030 (USD Million)
Table 121 Middle East & Africa Heparin Market, By Application, 2018 - 2030 (USD Million)
Table 122 Middle East & Africa Heparin Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 123 Middle East & Africa Heparin Market, By End-use, 2018 - 2030 (USD Million)
Table 124 Middle East & Africa Heparin Market, By Source, 2018 - 2030 (USD Million)
Table 125 Saudi Arabia Heparin Market, By Type, 2018 - 2030 (USD Million)
Table 126 Saudi Arabia Heparin Market, By Application, 2018 - 2030 (USD Million)
Table 127 Saudi Arabia Heparin Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 128 Saudi Arabia Heparin Market, By End-use, 2018 - 2030 (USD Million)
Table 129 Saudi Arabia Heparin Market, By Source, 2018 - 2030 (USD Million)
Table 130 South Africa Heparin Market, By Type, 2018 - 2030 (USD Million)
Table 131 South Africa Heparin Market, By Application, 2018 - 2030 (USD Million)
Table 132 South Africa Heparin Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 133 South Africa Heparin Market, By End-use, 2018 - 2030 (USD Million)
Table 134 South Africa Heparin Market, By Source, 2018 - 2030 (USD Million)
Table 135 UAE Heparin Market, By Type, 2018 - 2030 (USD Million)
Table 136 UAE Heparin Market, By Route of Administration, 2018 - 2030 (USD Million)
Table 137 UAE Heparin Market, By Application, 2018 - 2030 (USD Million)
Table 138 UAE Heparin Market, By End-use, 2018 - 2030 (USD Million)
Table 139 UAE Heparin Market, By Source, 2018 - 2030 (USD Million)
LIST OF FIGURES

Fig. 1 Heparin market segmentation
Fig. 2 Market research process
Fig. 3 Information procurement
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 QFD modeling for market share assessment
Fig. 8 Market formulation & validation
Fig. 9 Market outlook (2020)
Fig. 10 Strategy framework
Fig. 11 Market driver relevance analysis (Current & future impact)
Fig. 12 Market restraint relevance analysis (Current & future impact)
Fig. 13 Penetration & growth prospect mapping
Fig. 14 Porter’s five forces analysis
Fig. 15 PESTLE analysis
Fig. 16 Heparin market: type movement analysis
Fig. 17 Heparin market: type segment dashboard
Fig. 18 Heparin market type outlook: Key takeaways
Fig. 19 Low molecular weight heparin market, 2018 - 2030 (USD Million)
Fig. 20 Ultra-Low molecular weight heparin market, 2018 - 2030 (USD Million)
Fig. 21 Unfractionated heparin market, 2018 - 2030 (USD Million)
Fig. 22 Heparin market: route of administration movement analysis
Fig. 23 Heparin market: route of administration segment dashboard
Fig. 24 Heparin market dosage form outlook: Key takeaways
Fig. 25 Intravenous market, 2018 - 2030 (USD Million)
Fig. 26 Subcutaneous market, 2018 - 2030 (USD Million)
Fig. 27 Heparin market: application movement analysis
Fig. 28 Heparin market: application segment dashboard
Fig. 29 Heparin market application outlook: Key takeaways
Fig. 30 Venous thromboembolism market, 2018 - 2030 (USD Million)
Fig. 31 Coronary artery disease market, 2018 - 2030 (USD Million)
Fig. 32 Renal impairment market, 2018 - 2030 (USD Million)
Fig. 33 Atrial fibrillation market, 2018 - 2030 (USD Million)
Fig. 34 Others market, 2018 - 2030 (USD Million)
Fig. 35 Heparin market: end-use movement analysis
Fig. 36 Heparin market: end-use segment dashboard
Fig. 37 Heparin market end-use outlook: Key takeaways
Fig. 38 Outpatient market, 2018 - 2030 (USD Million)
Fig. 39 Inpatient market, 2018 - 2030 (USD Million)
Fig. 40 Heparin market: source movement analysis
Fig. 41 Heparin market: source segment dashboard
Fig. 42 Heparin market source outlook: Key takeaways
Fig. 43 Porcine market, 2018 - 2030 (USD Million)
Fig. 44 Bovine market, 2018 - 2030 (USD Million)
Fig. 45 Others market, 2018 - 2030 (USD Million)
Fig. 46 Regional outlook, 2021 & 2030
Fig. 47 Regional market dashboard
Fig. 48 Regional marketplace: Key takeaways
Fig. 49 North America, SWOT
Fig. 50 Europe, SWOT
Fig. 51 Asia Pacific, SWOT
Fig. 52 Latin America, SWOT
Fig. 53 Middle East and Africa, SWOT
Fig. 54 North America
Fig. 55 North America heparin market, 2018 - 2030 (USD Million)
Fig. 56 U.S.
Fig. 57 U.S. heparin market, 2018 - 2030 (USD Million)
Fig. 58 Canada
Fig. 59 Canada heparin market, 2018 - 2030 (USD Million)
Fig. 60 Europe
Fig. 61 Europe heparin market, 2018 - 2030 (USD Million)
Fig. 62 U.K.
Fig. 63 U.K. heparin market, 2018 - 2030 (USD Million)
Fig. 64 Germany
Fig. 65 Germany heparin market, 2018 - 2030 (USD Million)
Fig. 66 Spain
Fig. 67 Spain heparin market, 2018 - 2030 (USD Million)
Fig. 68 France
Fig. 69 France heparin market, 2018 - 2030 (USD Million)
Fig. 70 Italy
Fig. 71 Italy heparin market, 2018 - 2030 (USD Million)
Fig. 72 Russia
Fig. 73 Russia heparin market, 2018 - 2030 (USD Million)
Fig. 74 Asia Pacific
Fig. 75 Asia Pacific heparin market, 2018 - 2030 (USD Million)
Fig. 76 Japan
Fig. 77 Japan heparin market, 2018 - 2030 (USD Million)
Fig. 78 China
Fig. 79 China heparin market, 2018 - 2030 (USD Million)
Fig. 80 India
Fig. 81 India heparin market, 2018 - 2030 (USD Million)
Fig. 82 South Korea
Fig. 83 South Korea heparin market, 2018 - 2030 (USD Million)
Fig. 84 Australia
Fig. 85 Australia heparin market, 2018 - 2030 (USD Million)
Fig. 86 Singapore
Fig. 87 Singapore heparin market, 2018 - 2030 (USD Million)
Fig. 88 Latin America
Fig. 89 Latin America heparin market, 2018 - 2030 (USD Million)
Fig. 90 Brazil
Fig. 91 Brazil heparin market, 2018 - 2030 (USD Million)
Fig. 92 Mexico
Fig. 93 Mexico heparin market, 2018 - 2030 (USD Million)
Fig. 94 Argentina
Fig. 95 Argentina heparin market, 2018 - 2030 (USD Million)
Fig. 96 Middle East and Africa
Fig. 97 MEA heparin market, 2018 - 2030 (USD Million)
Fig. 98 South Africa
Fig. 99 South Africa heparin market, 2018 - 2030 (USD Million)
Fig. 100 Saudi Arabia
Fig. 101 Saudi Arabia heparin market, 2018 - 2030 (USD Million)
Fig. 102 UAE
Fig. 103 UAE heparin market, 2018 - 2030 (USD Million)
Fig. 104 Ansoff Matrix
Fig. 105 Heat map analysis
Fig. 106 Market differentiators


More Publications